Compugen Ltd. (TLV:CGEN)
525.00
-13.60 (-2.53%)
Jul 15, 2025, 5:24 PM IDT
Compugen Revenue
Compugen had revenue of $2.28M USD in the quarter ending March 31, 2025, a decrease of -10.75%. This brings the company's revenue in the last twelve months to $27.59M, down -23.40% year-over-year. In the year 2024, Compugen had annual revenue of $27.86M, down -16.72%.
Revenue (ttm)
$27.59M
Revenue Growth
-23.40%
P/S Ratio
4.86
Revenue / Employee
$372.82K
Employees
74
Market Cap
499.38M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.86M | -5.60M | -16.72% |
Dec 31, 2023 | 33.46M | 25.96M | 346.12% |
Dec 31, 2022 | 7.50M | 1.50M | 25.00% |
Dec 31, 2021 | 6.00M | 4.00M | 200.00% |
Dec 31, 2020 | 2.00M | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 61.87B |
Danel (Adir Yeoshua) | 2.81B |
Kamada | 622.70M |
Bait Bakfar | 104.50M |
SofWave Medical | 235.09M |
BrainsWay | 161.81M |
Novolog (Pharm-Up 1966) | 2.07B |
Ilex Medical | 922.08M |
Compugen News
- 4 weeks ago - Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences - PRNewsWire
- 5 weeks ago - DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer - Benzinga
- 2 months ago - Compugen Ltd. (CGEN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Compugen GAAP EPS of -$0.08, revenue of $2.3M - Seeking Alpha
- 2 months ago - Compugen Reports First Quarter 2025 Results - PRNewsWire
- 2 months ago - Compugen Q1 2025 Earnings Preview - Seeking Alpha
- 2 months ago - Uncovering Potential: Compugen's Earnings Preview - Benzinga
- 2 months ago - Compugen CEO Anat Cohen-Dayag to transition to executive chair - Seeking Alpha